Huge volumes of unstructured medical data are stored at the Russian hospitals and clinics. They can help to predict the health status of a patient using artificial intelligence and machine learning. The analyzed information opens up great prospects for pharmaceutical companies.
Is it possible to apply this data in scientific and marketing research for the pharmaceutical industry? What benefits can pharmaceutical companies using AI technology gain?
Alexandr Gusev, an expert in the field of digital health with 23 years of experience will answer these questions at M-Health Congress 2021.
At the conference, speaker will make a presentation on “Artificial intelligence as a tool for pharmaceutical companies: Application in research and production”.
Alexander is a Candidate of Technical Sciences and founder of Complex Medical Information Systems. He’s a member of the Expert Council on the use of information and communication technologies at the Ministry of Health of Russian Federation and a member of the Supervisory Board at National Base of Medical Knowledge – the Association of developers and users of artificial intelligence in healthcare.
The expert headed the team of developers of Kondopoga medical information system. Now he is an Editor-in-Chief at Doctor and Information Technologies magazine. Author of more than 100 scientific papers on digital health.
Join M-Health Congress on September 28 – learn about the application of artificial intelligence and other technologies in pharmaceutical industry.